| Metric | Q3'25 | Q4'25 | Change |
|---|---|---|---|
| Organic Revenue Growth | 6% (accelerating) | 5% (Q4) | -100 bps deceleration |
| Unit Case Volume | 1% (improving sequentially) | 1% (Q4) | Flat sequential momentum |
| Price/Mix | 6% (4% pricing + 2% mix) | 1% (4% pricing - 3% mix) | -500 bps mix deterioration |
| Comparable EPS | $0.82 (+6% YoY) | $0.58 (+6% YoY) | Maintained growth rate |
| North America Operating Margin | ~29% (estimated) | 30% (first time) | Crossed 30% threshold |
| Free Cash Flow | $8.5B (ex-fairlife) | $11.4B (ex-fairlife) | +$2.9B sequential jump |
| 2026 Organic Revenue Guidance | No guidance | 4-5% | Bottom of LTGA range |
| 2026 EPS Growth Guidance | No guidance | 7-8% (incl FX) | Below 8% target midpoint |
| Currency Impact 2026 | Slight tailwind expected | +1% revenue, +3% EPS | Meaningful FX boost |
| Latin America Volume | Flat | +1% (Q4) | Turned positive |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.